BSEM
BioStem Technologies, Inc.
Price Chart
Latest Quote
$5.37
Current Price| Previous Close | $6.20 |
| Open | $6.20 |
| Day High | $6.33 |
| Day Low | $5.05 |
| Volume | 86,287 |
Stock Information
| Shares Outstanding | 16.77M |
| Total Debt | $3.39M |
| Cash Equivalents | $27.16M |
| Revenue | $292.21M |
| Net Income | $20.20M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $90.03M |
| P/E Ratio | 6.10 |
| EPS (TTM) | $0.88 |
| Exchange | PNK |
📊 Custom Metrics & Score
Score: 29/42| Debt to Equity | 0.11 |
| Debt to Earnings | 0.02 |
| Current Ratio | 1.35 |
| Quick Ratio | 1.30 |
| Avg Revenue Growth | 1713.30% |
| Profit Margin | 10.56% |
| Return on Equity | 78.00% |
| Avg FCF Growth | -3973.15% |
| FCF Yield | 26.71% |
Score Explanation: The perfect score is 42/42 based on debt levels, profitability, growth rates, and cash flow metrics. FCF Yield is weighted most heavily as it shows what return the business currently generates.
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-02-02 | $5.37 | 86,287 |
| 2026-01-30 | $6.17 | 149,400 |
| 2026-01-29 | $7.05 | 169,300 |
| 2026-01-28 | $7.69 | 193,400 |
| 2026-01-27 | $8.20 | 329,300 |
| 2026-01-26 | $6.54 | 335,600 |
| 2026-01-23 | $7.15 | 605,500 |
| 2026-01-22 | $5.29 | 188,400 |
| 2026-01-21 | $4.69 | 176,700 |
| 2026-01-20 | $3.84 | 191,100 |
| 2026-01-16 | $4.20 | 141,300 |
| 2026-01-15 | $4.59 | 106,100 |
| 2026-01-14 | $4.99 | 41,300 |
| 2026-01-13 | $5.11 | 62,300 |
| 2026-01-12 | $5.30 | 188,800 |
| 2026-01-09 | $5.00 | 261,800 |
| 2026-01-08 | $4.25 | 69,200 |
| 2026-01-07 | $4.73 | 114,700 |
| 2026-01-06 | $4.26 | 104,000 |
| 2026-01-05 | $3.93 | 45,400 |
About BioStem Technologies, Inc.
BioStem Technologies, Inc. engages in the development, manufacturing, and commercialization of placental-derived allografts for advanced wound care and regenerative therapies in the United States. It offers Vendaje, a structural tissue allograft used as a protective covering for soft tissue wounds; Vendaje AC, a thicker structural tissue allograft used as a protective covering for soft tissue wounds; Vendaje OPTIC, a structural tissue allograft used as a protective covering during the repair of ocular surfaces; American Amnion AC, a human connective tissue matrix for homologous use; and American Amnion, a human connective tissue matrix for homologous use. The company was formerly known as Caribbean International Holdings Inc. and changed its name to BioStem Technologies, Inc. in August 2014. BioStem Technologies, Inc. was incorporated in 2006 and is based in Fort Lauderdale, Florida.
📰 Latest News
BioStem acquires BioTissue’s surgical and wound care assets in $40m deal
Medical Device Network • 2026-01-23T12:41:11Z
Assessing BioStem Technologies (OTCPK:BSEM) Valuation After Recent Share Price Strength
Simply Wall St. • 2026-01-11T05:09:57Z
Is It Time To Reassess BioStem Technologies (OTCPK:BSEM) After Its Recent Share Price Swings
Simply Wall St. • 2026-01-10T05:09:22Z
BioStem Technologies Inc (BSEM) Q3 2025 Earnings Call Highlights: Strong Demand and Strategic ...
GuruFocus.com • 2025-11-14T05:01:35ZIncome Statement (Annual)
Revenue
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Reconciled Cost Of Revenue | $13,673,904 | $1,260,548 | $902,706 | $1,474,882 |
| Cost Of Revenue | $13,745,825 | $1,260,558 | $881,754 | $1,474,771 |
| Total Revenue | $301,827,302 | $16,685,405 | $6,875,202 | $4,340,839 |
| Operating Revenue | $301,827,302 | $16,685,405 | $6,875,202 | $4,340,839 |
Expenses
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Interest Expense | $587,222 | $700,326 | $468,153 | $525,883 |
| Total Expenses | $270,626,661 | $24,464,374 | $11,556,750 | $5,946,544 |
| Net Non Operating Interest Income Expense | $-587,222 | $-700,326 | $-468,153 | $-525,883 |
| Interest Expense Non Operating | $587,222 | $700,326 | $468,153 | $525,883 |
| Operating Expense | $256,880,836 | $23,203,816 | $10,674,996 | $4,471,773 |
| Selling And Marketing Expense | $236,058,090 | $11,986,385 | $954,059 | $480,521 |
| General And Administrative Expense | $18,690,414 | $10,646,421 | $9,252,744 | $809,457 |
| Other Income Expense | - | $-3,689 | $-2,082,095 | $719,809 |
| Other Non Operating Income Expenses | - | $-3,689 | $1,102 | $30,448 |
| Other Operating Expenses | - | - | $8,530,960 | $3,378,414 |
Income & Earnings
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Net Income From Continuing Operation Net Minority Interest | $31,884,321 | $-8,482,984 | $-7,192,949 | $-1,445,383 |
| Net Interest Income | $-587,222 | $-700,326 | $-468,153 | $-525,883 |
| Normalized Income | $31,884,321 | $-8,482,984 | $-5,109,752 | $-2,134,744 |
| Net Income From Continuing And Discontinued Operation | $31,884,321 | $-8,482,984 | $-7,192,949 | $-1,445,383 |
| Total Operating Income As Reported | $31,200,641 | $-7,778,969 | $-4,681,548 | $-1,605,706 |
| Net Income Common Stockholders | $31,884,321 | $-8,482,984 | $-7,192,949 | $-1,445,383 |
| Net Income | $31,884,321 | $-8,482,984 | $-7,192,949 | $-1,445,383 |
| Net Income Including Noncontrolling Interests | $31,884,321 | $-8,482,984 | $-7,231,796 | $-1,411,780 |
| Net Income Continuous Operations | $31,884,321 | $-8,482,984 | $-7,231,796 | $-1,411,780 |
| Pretax Income | $30,613,419 | $-8,482,984 | $-7,231,796 | $-1,411,780 |
| Operating Income | $31,200,641 | $-7,778,969 | $-4,681,548 | $-1,605,706 |
| Depreciation Amortization Depletion Income Statement | $221,301 | $229,014 | $243,418 | $283,902 |
| Depreciation And Amortization In Income Statement | $221,301 | $229,014 | $243,418 | $283,902 |
| Gross Profit | $288,081,477 | $15,424,847 | $5,993,448 | $2,866,067 |
| Special Income Charges | - | $0 | $-2,083,197 | $689,361 |
Per Share Metrics
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Diluted EPS | $1.47 | $-0.62 | $-0.63 | $-0.12 |
| Basic EPS | $1.95 | $-0.62 | $-0.63 | $-0.12 |
Other
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $31,493,863 | $-7,553,634 | $-4,437,028 | $-1,291,356 |
| Reconciled Depreciation | $293,222 | $229,024 | $222,466 | $283,791 |
| EBITDA (Bullshit earnings) | $31,493,863 | $-7,553,634 | $-6,520,225 | $-601,995 |
| EBIT | $31,200,641 | $-7,782,658 | $-6,763,643 | $-885,897 |
| Diluted Average Shares | $21,698,384 | $13,748,035 | $11,404,995 | $11,685,291 |
| Basic Average Shares | $16,368,429 | $13,748,035 | $11,404,995 | $11,685,291 |
| Diluted NI Availto Com Stockholders | $31,884,321 | $-8,482,984 | $-7,192,949 | $-1,445,383 |
| Tax Provision | $-1,270,902 | $0 | $0 | $0 |
| Research And Development | $1,911,031 | $341,996 | $224,775 | $119,647 |
| Selling General And Administration | $254,748,504 | $22,632,806 | $10,206,803 | $809,457 |
| Other Gand A | $18,690,414 | $10,646,421 | $9,252,744 | $809,457 |
| Total Unusual Items | - | $0 | $-2,083,197 | $689,361 |
| Total Unusual Items Excluding Goodwill | - | $0 | $-2,083,197 | $689,361 |
| Minority Interests | - | $0 | $38,847 | $-33,602 |
| Gain On Sale Of Business | - | - | $0 | $33,925 |
| Other Special Charges | - | - | $2,083,197 | $-655,436 |
| Salaries And Wages | - | - | $8,530,960 | $3,378,414 |
Balance Sheet (Annual)
Assets
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Net Tangible Assets | $40,406,760 | $-1,936,615 | $-4,683,602 | $-6,414,081 |
| Total Assets | $140,375,727 | $14,560,291 | $3,466,433 | $2,671,515 |
| Total Non Current Assets | $6,614,618 | $1,961,238 | $1,979,932 | $1,732,913 |
| Non Current Deferred Assets | $4,179,632 | $0 | - | - |
| Non Current Deferred Taxes Assets | $4,179,632 | $0 | - | - |
| Goodwill And Other Intangible Assets | $468,772 | $592,239 | $607,206 | $454,683 |
| Other Intangible Assets | $224,137 | $347,604 | $362,571 | $210,048 |
| Current Assets | $133,761,109 | $12,599,053 | $1,486,501 | $938,601 |
| Other Current Assets | $2,874,317 | $329,239 | $281,930 | $38,083 |
| Inventory | $1,824,001 | $658,678 | $395,229 | $260,048 |
| Receivables | $106,230,085 | $11,371,730 | $37,206 | $300,137 |
| Loans Receivable | $1,250,000 | $0 | - | - |
| Accounts Receivable | $104,980,085 | $11,371,730 | $37,206 | $300,137 |
| Allowance For Doubtful Accounts Receivable | $-223,166 | $-48,166 | $-115,149 | $0 |
| Gross Accounts Receivable | $105,203,251 | $11,419,896 | $152,356 | $300,137 |
| Cash Cash Equivalents And Short Term Investments | $22,832,706 | $239,406 | $772,136 | $340,333 |
| Cash And Cash Equivalents | $22,832,706 | $239,406 | $772,136 | $340,333 |
| Cash Financial | $22,832,706 | $239,406 | $772,136 | $340,333 |
Debt
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Total Debt | $4,394,701 | $4,723,699 | $5,089,034 | $4,831,187 |
| Long Term Debt And Capital Lease Obligation | $330,235 | $268,929 | $1,037,767 | $1,804,309 |
| Long Term Debt | $150,000 | $265,635 | $1,026,462 | $1,797,766 |
| Current Debt And Capital Lease Obligation | $4,064,466 | $4,454,770 | $4,051,267 | $3,026,878 |
| Current Debt | $3,957,744 | $4,445,782 | $4,042,029 | $3,000,000 |
| Other Current Borrowings | $3,957,744 | $4,445,782 | $4,042,029 | $3,000,000 |
| Net Debt | - | $4,472,011 | $4,296,355 | $4,457,433 |
Liabilities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Total Liabilities Net Minority Interest | $99,500,195 | $15,904,667 | $7,416,385 | $8,465,622 |
| Total Non Current Liabilities Net Minority Interest | $330,235 | $283,779 | $1,088,279 | $1,924,516 |
| Current Liabilities | $99,169,960 | $15,620,888 | $6,328,106 | $6,541,106 |
| Other Current Liabilities | $711,361 | $289,409 | $228,303 | $397,884 |
| Payables And Accrued Expenses | $94,394,133 | $10,876,709 | $2,048,536 | $3,116,344 |
| Interest Payable | $1,962,983 | $1,697,787 | $1,478,421 | $1,301,670 |
| Payables | $92,431,150 | $9,178,922 | $570,115 | $1,814,674 |
| Other Payable | $84,232,633 | $8,308,686 | - | $1,167,418 |
| Total Tax Payable | $2,908,730 | $0 | - | - |
| Income Tax Payable | $2,908,730 | $0 | - | - |
| Accounts Payable | $5,289,787 | $870,236 | $570,115 | $647,256 |
| Other Non Current Liabilities | - | $14,850 | $50,512 | $120,207 |
| Current Notes Payable | - | - | - | $3,597,607 |
Equity
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Common Stock Equity | $40,875,532 | $-1,344,376 | $-4,076,396 | $-5,959,398 |
| Total Equity Gross Minority Interest | $40,875,532 | $-1,344,376 | $-3,949,952 | $-5,794,107 |
| Stockholders Equity | $40,875,532 | $-1,344,376 | $-4,076,396 | $-5,959,398 |
| Retained Earnings | $-13,739,796 | $-45,624,117 | $-37,141,133 | $-29,948,285 |
| Other Equity Interest | - | - | - | $1,192 |
Other
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Treasury Shares Number | $18,000 | $18,000 | - | - |
| Ordinary Shares Number | $16,643,482 | $16,214,390 | $12,161,047 | - |
| Share Issued | $16,661,482 | $16,232,390 | $12,161,047 | - |
| Tangible Book Value | $40,406,760 | $-1,936,615 | $-4,683,602 | $-6,414,081 |
| Invested Capital | $44,983,276 | $3,367,041 | $992,095 | $-1,161,632 |
| Working Capital | $34,591,149 | $-3,021,835 | $-4,841,605 | $-5,602,505 |
| Capital Lease Obligations | $286,957 | $12,282 | $20,543 | $33,421 |
| Total Capitalization | $41,025,532 | $-1,078,741 | $-3,049,934 | $-4,161,632 |
| Treasury Stock | $43,346 | $43,346 | $43,346 | $43,346 |
| Additional Paid In Capital | $54,642,012 | $44,306,872 | $33,095,921 | $24,022,489 |
| Capital Stock | $16,662 | $16,215 | $12,162 | $9,744 |
| Common Stock | $16,662 | $16,215 | $12,162 | $9,744 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $180,235 | $3,294 | $11,305 | $6,543 |
| Current Capital Lease Obligation | $106,722 | $8,988 | $9,238 | $26,878 |
| Current Accrued Expenses | $1,962,983 | $1,697,787 | $1,478,421 | $1,301,670 |
| Goodwill | $244,635 | $244,635 | $244,635 | $244,635 |
| Net PPE | $1,966,214 | $1,368,999 | $1,372,726 | $1,278,230 |
| Accumulated Depreciation | $-1,196,640 | $-1,110,828 | $-1,010,160 | $-874,114 |
| Gross PPE | $3,162,854 | $2,479,827 | $2,382,886 | $2,152,344 |
| Construction In Progress | $190,422 | $202,700 | $103,110 | $0 |
| Other Properties | $271,214 | $11,443 | $19,832 | $32,868 |
| Machinery Furniture Equipment | $1,392,140 | $1,063,102 | $1,063,102 | $934,790 |
| Buildings And Improvements | $1,234,078 | $1,127,582 | $1,121,842 | $1,109,686 |
| Land And Improvements | $75,000 | $75,000 | $75,000 | $75,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $1,647,783 | $589,205 | $346,189 | $197,867 |
| Raw Materials | $176,218 | $69,473 | $72,090 | $28,087 |
| Minority Interest | - | $0 | $126,444 | $165,291 |
| Inventories Adjustments Allowances | - | $0 | $-25,000 | $98,937 |
| Other Inventories | - | - | $1,950 | - |
| Work In Process | - | - | - | $98,937 |
Cash Flow Statement (Annual)
Free Cash Flow
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | $24,050,084 | $-3,709,290 | $-165,909 | $-152,287 |
Operating Activities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Operating Cash Flow | $24,476,653 | $-3,498,960 | $303,575 | $-109,439 |
| Cash Flow From Continuing Operating Activities | $24,476,653 | $-3,498,960 | $303,575 | $-109,440 |
| Operating Gains Losses | - | - | $2,083,197 | $-689,361 |
Investing Activities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Capital Expenditure | $-426,569 | $-210,330 | $-469,484 | $-42,848 |
| Investing Cash Flow | $-1,676,569 | $-210,330 | $-469,484 | $-7,848 |
| Cash Flow From Continuing Investing Activities | $-1,676,569 | $-210,330 | $-469,484 | $-7,848 |
| Net Other Investing Changes | $-1,250,000 | - | - | - |
Financing Activities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Repurchase Of Capital Stock | $-1 | $0 | - | - |
| Financing Cash Flow | $-206,784 | $3,176,560 | $597,712 | $357,421 |
| Cash Flow From Continuing Financing Activities | $-206,784 | $3,176,560 | $597,712 | $357,421 |
| Net Common Stock Issuance | $-1 | $0 | $50,000 | $125,000 |
| Issuance Of Capital Stock | - | $2,379,500 | $50,000 | $125,000 |
| Common Stock Issuance | - | $2,379,500 | $50,000 | $125,000 |
Other
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Repayment Of Debt | $-849,400 | $-771,659 | $-552,288 | $-63,079 |
| Issuance Of Debt | $0 | $1,568,719 | $1,100,000 | $295,500 |
| Interest Paid Supplemental Data | $136,922 | $480,960 | $226,465 | $333,173 |
| Income Tax Paid Supplemental Data | $0 | $0 | $0 | $0 |
| End Cash Position | $22,832,706 | $239,406 | $772,136 | $340,333 |
| Beginning Cash Position | $239,406 | $772,136 | $340,333 | $100,199 |
| Changes In Cash | $22,593,300 | $-532,730 | $431,803 | $240,134 |
| Proceeds From Stock Option Exercised | $642,617 | $2,379,500 | - | - |
| Common Stock Payments | $-1 | $0 | - | - |
| Net Issuance Payments Of Debt | $-849,400 | $797,060 | $547,712 | $232,421 |
| Net Long Term Debt Issuance | $-849,400 | $797,060 | $547,712 | $232,421 |
| Long Term Debt Payments | $-849,400 | $-771,659 | $-552,288 | $-63,079 |
| Long Term Debt Issuance | $0 | $1,568,719 | $1,100,000 | $295,500 |
| Net Intangibles Purchase And Sale | $0 | $-105,000 | $-225,907 | $0 |
| Purchase Of Intangibles | $0 | $-105,000 | $-225,907 | $0 |
| Net PPE Purchase And Sale | $-426,569 | $-105,330 | $-243,577 | $-42,848 |
| Purchase Of PPE | $-426,569 | $-105,330 | $-243,577 | $-42,848 |
| Change In Working Capital | $-12,010,879 | $-2,720,907 | $-297,555 | $515,904 |
| Change In Other Current Liabilities | $353,658 | $25,444 | $-239,277 | $96,852 |
| Change In Payables And Accrued Expense | $83,517,424 | $8,898,931 | $208,046 | $563,681 |
| Change In Accrued Expense | $265,196 | $290,150 | $285,186 | $583,172 |
| Change In Interest Payable | $265,196 | $290,150 | $226,465 | $333,173 |
| Change In Payable | $83,252,228 | $8,608,781 | $-77,140 | $-19,491 |
| Change In Account Payable | $4,419,551 | $300,095 | $-77,140 | $-19,491 |
| Change In Tax Payable | $2,908,730 | $0 | - | - |
| Change In Income Tax Payable | $2,908,730 | $0 | - | - |
| Change In Prepaid Assets | $-933,283 | $-47,308 | $-243,847 | $31,123 |
| Change In Inventory | $-1,165,323 | $-263,450 | $-135,180 | $209,346 |
| Change In Receivables | $-93,783,355 | $-11,334,524 | $112,703 | $-288,246 |
| Changes In Account Receivables | $-93,783,355 | $-11,334,524 | $112,703 | $-288,246 |
| Other Non Cash Items | $458,832 | $1,720,051 | $473,851 | $788,987 |
| Stock Based Compensation | $6,663,684 | $5,755,856 | $4,903,184 | $403,021 |
| Provisionand Write Offof Assets | $175,000 | $0 | $150,228 | - |
| Amortization Of Securities | $1,192,105 | $0 | - | - |
| Deferred Tax | $-4,179,632 | $0 | - | - |
| Deferred Income Tax | $-4,179,632 | $0 | - | - |
| Depreciation Amortization Depletion | $293,222 | $229,024 | $222,466 | $283,791 |
| Depreciation And Amortization | $293,222 | $229,024 | $222,466 | $283,791 |
| Amortization Cash Flow | $132,176 | $128,356 | $86,420 | $104,767 |
| Amortization Of Intangibles | $132,176 | $128,356 | $86,420 | $104,767 |
| Depreciation | $161,046 | $100,668 | $136,046 | $179,024 |
| Net Income From Continuing Operations | $31,884,321 | $-8,482,984 | $-7,231,796 | $-1,411,781 |
| Net Business Purchase And Sale | - | - | $0 | $35,000 |
| Sale Of Business | - | - | $0 | $35,000 |
| Net Foreign Currency Exchange Gain Loss | - | - | $0 | $-655,436 |
| Gain Loss On Sale Of Business | - | - | $0 | $-33,925 |
| Sale Of PPE | - | - | - | $60,866 |
| Change In Other Current Assets | - | - | - | $489 |
| Gain Loss On Sale Of PPE | - | - | - | $-103,714 |